25O-NBcP
Chemical compound
25O-NBcP is a synthetic psychedelic compound that belongs to the NBOMe class of drugs. It is a derivative of the phenethylamine 2C-B and is known for its potent hallucinogenic effects. The compound is chemically related to other substances in the NBOMe series, such as 25I-NBOMe and 25C-NBOMe.
Chemical Structure and Properties
25O-NBcP is characterized by the presence of a methoxy group at the 2-position of the phenethylamine backbone, and a 2-methoxybenzyl group attached to the nitrogen atom. This structural modification is responsible for its high affinity for the 5-HT2A receptor, which is believed to be the primary mechanism of its psychedelic effects.
The chemical formula of 25O-NBcP is C18H22ClNO3, and it has a molecular weight of 335.83 g/mol. The compound is typically synthesized in a laboratory setting and is not found naturally.
Pharmacology
25O-NBcP acts as a potent agonist at the 5-HT2A receptor, which is a subtype of the serotonin receptor family. Activation of this receptor is associated with the psychedelic effects experienced by users, including altered perception, mood changes, and visual hallucinations. The compound may also interact with other serotonin receptor subtypes, contributing to its overall pharmacological profile.
Effects
The effects of 25O-NBcP are similar to those of other NBOMe compounds and can include:
- Intense visual hallucinations
- Altered perception of time and space
- Euphoria
- Enhanced sensory experiences
- Changes in thought patterns
The onset of effects typically occurs within 30 to 90 minutes after ingestion, with the peak effects lasting for several hours. The duration of the experience can vary depending on the dose and individual metabolism.
Safety and Toxicity
The safety profile of 25O-NBcP is not well-established, and there is limited research on its toxicity in humans. As with other NBOMe compounds, there is a potential for adverse effects, especially at higher doses. These can include:
- Increased heart rate and blood pressure
- Agitation and anxiety
- Nausea and vomiting
- Risk of serotonin syndrome
Due to the potential for serious adverse effects, caution is advised when using this compound, and it is not recommended for recreational use.
Legal Status
The legal status of 25O-NBcP varies by country. In some jurisdictions, it may be classified as a controlled substance, while in others, it may not be specifically regulated. Users should be aware of the legal implications of possessing or distributing this compound in their region.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD